News
ChemPartner’s Strategic Response to Global Trade Developments
Our top priority at ChemPartner is ensuring the continuity of service and scientific integrity across all programs entrusted to us. As shifts in international policy continue to influence the economic landscape, particularly in the relationship between the United...
ChemPartner and Hong Kong Polytechnic University Sign MOU
On August 9, 2024, Shanghai ChemPartner Co., Ltd (ChemPartner) and the Hong Kong Polytechnic University (PolyU) marked the signing of a Memorandum of Understanding (MOU). The MOU was signed by Professor Larry Ming Cheung Chow, Head of the Department of Applied Biology...
ChemPartner Unveils Highly Anticipated Biology Database
Newly-launched database offers easier access to diverse tumor models and unveils the path to pharmaceutical breakthroughs ChemPartner, a global leader in drug discovery and development services, today announced the launch of its long-awaited Biology Database....
Dr. Yinfei Yin Joins Shanghai ChemPartner as Vice President and Head of Biology and Pharmacology
ChemPartner announced today the appointment of Yinfei Yin, Ph.D. as vice president of and head of the biology and pharmacology department at Shanghai ChemPartner. Dr. Yin brings a wealth of experience and expertise to his new role, having established himself as a...
ChemPartner Receives 2023 CDMO Leadership Awards
There are six core categories in the CDMO Leadership Awards: Capabilities, Compatibility, Expertise, Quality, Reliability and...
Dr. Cheng-Chi Chao joins ChemPartner as Vice President and Head of Immunotherapy and Inflammation
Shanghai, China (March 23, 2020) – Shanghai ChemPartner announced today the appointment of Cheng-Chi Chao, Ph.D. as Vice President and Head of Immunotherapy and Inflammation. Dr. Chao has over 20 years of experience in drug development and extensive expertise in the...
ChemPartner Makes Additional Investments in Biologics from Research to Manufacturing Capabilities
Shanghai, China (June 9, 2020) – Shanghai ChemPartner announced the additional investments the company is making into its biologics business unit to further its capabilities and capacity in biologics discovery through development and manufacturing. “ChemPartner has...
ChemPartner Assists the Mount Sinai Health System in Producing Reagent for COVID-19 Research
Shanghai, China (May 12, 2020) – Shanghai ChemPartner announced they have entered into a non-exclusive agreement with the Mount Sinai Health System (Mount Sinai) to assist in a trial production run of a component of the Mount Sinai COVID-19 serological assay that...
Headquarters
1F & 3F, Block A
2829 JinKe Road
Zhangjiang Hi-Tech Park
PuDong New Area
Shanghai China, 201203
Contact Us
China: +86 21 5132 0088
US: +1 650 419 9974
Europe: +45 4586 9000